Iqvia Holdings (IQV) Income from Continuing Operations (2012 - 2026)
Iqvia Holdings (IQV) posted Income from Continuing Operations of 241000000.0 for Q2 2026, down 10.41% sequentially from 269000000.0 in Q1 2026, and down 9.74% YoY from 267000000.0 in Q2 2025.
Iqvia Holdings (IQV) Income from Continuing Operations (2012 - 2026) Analysis & Trends
Iqvia Holdings has reported Income from Continuing Operations for 15 years, with the latest figure at 241000000.0 in Q2 2026.
- Quarterly Income from Continuing Operations fell 9.74% year-over-year to 241000000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 1320000000.0 (up 6.02% YoY) and the FY2025 annual result came in at 1339000000.0, down 2.12% from the prior year.
- Income from Continuing Operations eased to 241000000.0 in Q2 2026 per IQV's latest filing, from 269000000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 478000000.0 in Q4 2025 and troughed at 227000000.0 in Q4 2022.
- A 5-year average of 315444444.44 and a median of 291000000.0 in 2023 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2022 and 2023: Income from Continuing Operations dropped 28.39% in 2022, then soared 109.25% in 2023.
- Over 5 years, Income from Continuing Operations stood at 227000000.0 in 2022, then jumped by 109.25% to 475000000.0 in 2023, then slipped by 9.05% to 432000000.0 in 2024, then increased by 10.65% to 478000000.0 in 2025, then plunged by 49.58% to 241000000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 241000000.0, 269000000.0, and 478000000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.98 Bn | 209.91 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 140.49 Bn | 136.14 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Idexx Laboratories | 46.39 Bn | 46.19 Bn | 779.09 Mn | 338.41 Mn |
| 4 | Agilent Technologies | 39.72 Bn | 37.91 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 39.38 Bn | 37.30 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Natera | 38.92 Bn | 37.82 Bn | 696.04 Mn | -85.11 Mn |
| 7 | Illumina | 30.08 Bn | 28.91 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.65 Bn | 28.60 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Quest Diagnostics | 26.23 Bn | 25.60 Bn | 1.03 Bn | 324.00 Mn |
| 10 | Labcorp Holdings | 25.87 Bn | 24.89 Bn | 1.01 Bn | 278.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 241.00 Mn |
| Mar 31, 2026 | 269.00 Mn |
| Dec 31, 2025 | 478.00 Mn |
| Sep 30, 2025 | 332.00 Mn |
| Jun 30, 2025 | 267.00 Mn |
| Mar 31, 2025 | 262.00 Mn |
| Dec 31, 2024 | 432.00 Mn |
| Sep 30, 2024 | 284.00 Mn |
| Jun 30, 2024 | 361.00 Mn |
| Mar 31, 2024 | 291.00 Mn |
| Dec 31, 2023 | 475.00 Mn |
| Sep 30, 2023 | 298.00 Mn |
| Jun 30, 2023 | 294.00 Mn |
| Mar 31, 2023 | 291.00 Mn |
| Dec 31, 2022 | 227.00 Mn |
| Sep 30, 2022 | 290.00 Mn |
| Jun 30, 2022 | 257.00 Mn |
| Mar 31, 2022 | 329.00 Mn |
| Dec 31, 2021 | 317.00 Mn |
| Sep 30, 2021 | 261.00 Mn |